180 related articles for article (PubMed ID: 11849266)
1. Cost of nonmelanoma skin cancer treatment in the United States.
Chen JG; Fleischer AB; Smith ED; Kancler C; Goldman ND; Williford PM; Feldman SR
Dermatol Surg; 2001 Dec; 27(12):1035-8. PubMed ID: 11849266
[TBL] [Abstract][Full Text] [Related]
2. Nonmelanoma skin cancer: an episode of care management approach.
Housman TS; Williford PM; Feldman SR; Teuschler HV; Fleischer AB; Goldman ND; Balkrishnan R; Chen GJ
Dermatol Surg; 2003 Jul; 29(7):700-11. PubMed ID: 12828693
[TBL] [Abstract][Full Text] [Related]
3. Skin cancer is among the most costly of all cancers to treat for the Medicare population.
Housman TS; Feldman SR; Williford PM; Fleischer AB; Goldman ND; Acostamadiedo JM; Chen GJ
J Am Acad Dermatol; 2003 Mar; 48(3):425-9. PubMed ID: 12637924
[TBL] [Abstract][Full Text] [Related]
4. Treatment patterns and cost of nonmelanoma skin cancer management.
John Chen G; Yelverton CB; Polisetty SS; Housman TS; Williford PM; Teuschler HV; Feldman SR
Dermatol Surg; 2006 Oct; 32(10):1266-71. PubMed ID: 17034377
[TBL] [Abstract][Full Text] [Related]
5. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
[TBL] [Abstract][Full Text] [Related]
6. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.
Rogers HW; Coldiron BM
J Am Acad Dermatol; 2009 Jul; 61(1):96-103. PubMed ID: 19539843
[TBL] [Abstract][Full Text] [Related]
7. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC
Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467
[TBL] [Abstract][Full Text] [Related]
8. Skin cancer (Basal cell carcinoma, squamous cell carcinoma, and malignant melanoma): new cases, treatment practice, and health care costs in new brunswick, Canada, 2002-2010.
Pilgrim W; Hayes R; Hanson DW; Zhang B; Boudreau B; Leonfellner S
J Cutan Med Surg; 2014 Oct; 18(5):320-31. PubMed ID: 25186993
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of nonmelanoma skin cancer screening in Crohn's disease patients.
Okafor PN; Stallwood CG; Nguyen L; Sahni D; Wasan SK; Farraye FA; Erim DO
Inflamm Bowel Dis; 2013 Dec; 19(13):2787-95. PubMed ID: 24193153
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and economic burden of nonmelanoma skin cancer.
Cakir BÖ; Adamson P; Cingi C
Facial Plast Surg Clin North Am; 2012 Nov; 20(4):419-22. PubMed ID: 23084294
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of Mohs micrographic surgery: review of the literature.
Tierney EP; Hanke CW
J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
[TBL] [Abstract][Full Text] [Related]
12. The economic impact of non-melanoma skin cancer: a review.
Mudigonda T; Pearce DJ; Yentzer BA; Williford P; Feldman SR
J Natl Compr Canc Netw; 2010 Aug; 8(8):888-96. PubMed ID: 20870635
[TBL] [Abstract][Full Text] [Related]
13. Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting.
Wilson LS; Pregenzer M; Basu R; Bertenthal D; Torres J; Asgari M; Chren MM
Dermatol Surg; 2012 Apr; 38(4):570-84. PubMed ID: 22145798
[TBL] [Abstract][Full Text] [Related]
14. No end in sight: the skin cancer epidemic continues.
Donaldson MR; Coldiron BM
Semin Cutan Med Surg; 2011 Mar; 30(1):3-5. PubMed ID: 21540015
[TBL] [Abstract][Full Text] [Related]
15. Estimating the health care costs of non-melanoma skin cancer in Saskatchewan using physician billing data.
Tran DA; Coronado AC; Sarker S; Alvi R
Curr Oncol; 2019 Apr; 26(2):114-118. PubMed ID: 31043813
[TBL] [Abstract][Full Text] [Related]
16. Physician specialty cost differences of treating nonmelanoma skin cancer.
Chirikov VV; Stuart B; Zuckerman IH; Christy MR
Ann Plast Surg; 2015 Jan; 74(1):93-9. PubMed ID: 24503881
[TBL] [Abstract][Full Text] [Related]
17. Mohs micrographic surgery: a cost analysis.
Cook J; Zitelli JA
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of nonmelanoma skin cancer in the Medicare population.
Manternach T; Housman TS; Williford PM; Teuschler H; Fleischer AB; Feldman SR; Chen GJ
Dermatol Surg; 2003 Dec; 29(12):1167-9; discussion 1169. PubMed ID: 14725656
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of office-based visits for skin cancer. Dermatologists have more experience than other physicians in managing malignant and premalignant skin conditions.
Smith ES; Feldman SR; Fleischer AB; Leshin B; McMichael A
Dermatol Surg; 1998 Sep; 24(9):981-5. PubMed ID: 9754086
[TBL] [Abstract][Full Text] [Related]
20. Incidence estimate of nonmelanoma skin cancer in the United States, 2006.
Rogers HW; Weinstock MA; Harris AR; Hinckley MR; Feldman SR; Fleischer AB; Coldiron BM
Arch Dermatol; 2010 Mar; 146(3):283-7. PubMed ID: 20231499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
